The Psychopharmacology Research Consortium is a division of the University of Nebraska Department of Psychiatry. The Research Consortium was organized in 1984 to investigate pharmacologic approaches to the treatment of mental disorders.
The Consortium works in conjunction with the National Institutes of Health (NIH) as well as pharmaceutical companies in the evaluation of potentially innovative treatments for a wide range of disorders in adults and children. All studies are approved by the University of Nebraska Institutional Review Board which serves to protect the rights of persons who participate in research studies.
For more information go to the Consortium Web site at Psychopharmacology Research Consortium